Prenatal imaging: Ultrasonography and magnetic resonance imaging

Obstetrics and Gynecology

Volumn 112, Issue 1, 2008, Pages 145-157

  Reddy, Uma M ^a   Filly, Roy A ^a   Copel, Joshua A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PROTEIN A;

ALLOIMMUNIZATION; ANEMIA; ANEUPLOIDY; ARTERY BLOOD FLOW; BODY TEMPERATURE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN VENTRICLE DILATATION; CENTRAL NERVOUS SYSTEM MALFORMATION; CLEFT FACE; CONGENITAL DIAPHRAGM HERNIA; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; DOWN SYNDROME; EXPERIENCE; FETUS (ANATOMY); FETUS DISEASE; FETUS ECHOGRAPHY; FETUS GROWTH; FETUS MALFORMATION; FETUS MONITORING; FETUS SURGERY; FETUS WEIGHT; FIRST TRIMESTER PREGNANCY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC MARKER; GENETIC RISK; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HUMAN; IMAGE QUALITY; IMAGE RECONSTRUCTION; INTERMETHOD COMPARISON; INTRAUTERINE GROWTH RETARDATION; INVASIVE PROCEDURE; LIVER WEIGHT; MACROSOMIA; MAGNETOENCEPHALOGRAPHY; MULTIPLE PREGNANCY; NEURAL TUBE DEFECT; NOTE; NUCHAL TRANSLUCENCY MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITION; PARAMEDICAL EDUCATION; PATIENT COUNSELING; PATIENT SAFETY; PERINATAL MORTALITY; PLACENTA ACCRETA; PLACENTA PREVIA; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL CARE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIOFREQUENCY; RISK ASSESSMENT; SACROCOCCYX TUMOR; SECOND TRIMESTER PREGNANCY; SEDATION; SIGNAL NOISE RATIO; SKELETON MALFORMATION; STILLBIRTH; THREE DIMENSIONAL IMAGING; TRISOMY 21; TROPHOBLAST; UTERINE ARTERY; VOLUMETRY; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; ECHOGRAPHY; FEMALE; PREGNANCY;

FEMALE; FETAL DISEASES; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; PREGNANCY; PRENATAL CARE; ULTRASONOGRAPHY, PRENATAL;

EID: 48549094760     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000318871.95090.d9     Document Type: Note

References (54)

1. Diagnostic ultrasound imaging in pregnancy. National Institutes of Health Consensus Development Conference Statement February 6-8, 1984. Available at: http://www.ncbi.nlm.nih.gov/ books/bv.fcgi?indexed=google&rid= hstat6.chapter.49461. Retrieved February 27, 2007.
2. Ewigman BG, Crane JP, Frigoletto FD, LeFevre ML, Bain RP, McNellis D. Effect of prenatal ultrasound screening on perinatal outcome. RADIUS Study Group. N EnglJ Med 1993;329:821-7.
3. Saari-Kemppainen A, Karjalainen O, Ylostalo P, Heinonen OP. Ultrasound screening and perinatal mortality: controlled trial of systematic one-stage screening in pregnancy. The Helsinki Ultrasound Trial. Lancet 1990;336: 387-9.
4. Crane JP, LeFevre ML, Winborn RC, Evans JK, Ewigman BG, Bain RP, Frigoletto FD, McNellis D. A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. The RADIUS Study Group. Am J Obstet Gynecol 1994;171: 392-9.
5. Martin JA, Hamilton BE, Ventura SJ, Menacker F, Park MM, Births: final data for 2000. National Vital Statistics Reports, vol. 50, no. 5. Hyattsville (MD): National Center for Health Statistics; 2002. Available at: www.cdc.gov/ nchs/data/nvsr/nvsr50/nvsr50-05.pdf. Retrieved December 13, 2007.
6. Screening for fetal chromosomal abnormalities. ACOG Practice Bulletin No. 77. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;109:217-27.
7. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353: 2001-11.
8. Carvalho MH, Brizot ML, Lopes LM, Chiba CH, Miyadahira S, Zugaib M. Detection of fetal structural abnormalities at the 11-14 week ultrasound scan. Prenat Diagn 2002;22:1-4.
9. D'Ottavio G, Mandruzzato G, Meir YJ, Rustico MA, Fischer-Tamaro L, Conoscenti G, et al. Comparisons of first and second trimester screening for fetal anomalies. Ann N Y Acad Sci 1998;847:200-9.
10. den Hollander NS, Wessels MW, Niermeijer MF, Los FJ, Wladimiroff JW. Early fetal anomaly scanning in a population at increased risk of abnormalities. Ultrasound Obstet Gynecol 2002;19:570-4.
11. Taipale P, Ammälä M, Salonen R, Hiilesmaa V. Learning curve in ultrasonographic screening for selected fetal structural anomalies in early pregnancy. Obstet Gynecol 2003; 101: 273-8.
12. Grandjean H, Larroque D, Levi S. The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study. Am J Obstet Gynecol 1999;181:446-54.
13. Nyberg DA, Luthy DA, Resta RG, Nyberg BC, Williams MA. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 1998; 12: 8-14.
14. HobbinsJC, Lezotte DC, Persutte WH, DeVore GR, Benacerraf BR, Nyberg DA, et al. An 8-center study to evaluate the utility of mid-term genetic sonograms among high-risk pregnancies. J Ultrasound Med 2003;22:33-8.
15. DeVore GR. Trisomy 21: 95% detection rate using second-trimester ultrasound markers. Ultrasound Obstet Gynecol 2000;16:133-41.
16. Smith-Bindman R, Hosmer W, Feldstein VA, DeeksJJ, GoldbergJD. Second-trimester ultrasound to detect fetuses with Down syndrome: a metaanalysis. JAMA 2001;285:1044-55.
17. Goncalves LF, Lee W, Espinoza J, Romero R. Three- and 4-dimensional ultrasound in obstetric practice: does it help? J Ultrasound Med 2005;24: 1599-624.
18. Goncalves LF, Nien JK, Espinoza J, KusanovicJP, Lee W, Swope B, et al. What does 2-dimensional imaging add to 3- and 4-dimensional obstetric ultrasonography? J Ultrasound Med 2006 Jun;25:691-9.
19. Gardosi J, Kady SM, McGeown P, Francis A, Tonks A. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ 2005;331:1113-7.
20. American College of Obstetricians and Gynecologists. Intrauterine growth restriction. ACOG Practice Bulletin No. 12. In: 2005 Compendium of selected publications. Washington (DC): ACOG; 2006. p. 483-93.
21. Baschat AA, Cosmi E, Bilardo CM, Wolf H, Berg C, Rigano S, et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 2007;109:253-61.
22. Jeanty P, Romero R, HobbinsJC. Fetal limb volume: a new parameter to assess fetal growth and nutrition. J Ultrasound Med 1985;4:273-82.
23. Lee W, Deter RL, Ebersole JD, Huang R, Blanckaert K, Romero R. Birth weight prediction by three-dimensional ultrasonography: fractional limb volume. J Ultrasound Med 2001;20: 1283-92.
24. Papageorghiou AT, Leslie K. Uterine artery Doppler in the prediction of adverse pregnancy outcome. Curr Opin Obstet Gynecol 2007;19:103-9.
25. Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000;342:9-14.
26. Trends in infant mortality attributable to birth defects-United States, 1980-1995. Available at http://www.cdc.gov/ mmwR/preview/mmwrhtml/00054921. htm. Retrieved May 20, 2008.
27. Lee W. Performance of the basic fetal cardiac ultrasound examination [published erratum appears in J Ultrasound Med 1998;17:796]. J Ultrasound Med 1998;17:601-7.
28. Verheijen PM, Lisowski LA, Stouten-beek P, HitchcockJF, BrennerJI, Copel JA, et al. Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn patient. J Tho-rac Cardiovasc Surg 2001; 121:798-803.
29. Chang AC, HuhtaJC, Yoon GY, Wood DC, Tulzer G, Cohen A, et al. Diagnosis, transport, and outcome in fetuses with left ventricular outflow tract obstruction. J Thorac Cardiovasc Surg 1991;102:841-8.
30. AbramowiczJS. Technical advances in ultrasound equipment. Clin Obstet Gynecol 2003;46:839-49.
31. Miller MW, Brayman AA, Abramowicz JS. Obstetric ultrasonography: a biophysical consideration of patient safety-the "rules" have changed. Am J Obstet Gynecol 1998;179:241-54.
32. U.S. Food and Drug Administration Center for Devices and Radiological Health. Fetal keepsake videos. Available at: http://www.fda.gov/cdrh/ consumer/fetalvideos.html. Retrieved May 20, 2008.
33. Salvesen KA, Eik-Nes SH. Is ultrasound unsound? A review of epidemiological studies of human exposure to ultrasound. Ultrasound Obstet Gynecol 1995;6:293-8.
34. Newnham JP, Evans SF, Michael CA, Stanley FJ, Landau LI. Effects of frequent ultrasound during pregnancy: a randomised controlled trial. Lancet 1993;342:887-91.
35. Kieler H, Cnattingius S, Haglund B, Palmgren J, Axelsson O. Sinistrality-a side-effect of prenatal sonography: a comparative study of young men. Epidemiology 2001;12:618-23.
36. Campbell JD, Elford RW, Brant RF. Case-control study of prenatal ultrasonography exposure in children with delayed speech. CMAJ 1993;149:1435-40.
37. Ang ES Jr., Gluncic V, Duque A, Schafer ME, Rakic P. Prenatal exposure to ultrasound waves impacts neuronal migration in mice. Proc Natl Acad Sci U S A 2006;103:12903-10.
38. Levine D, Barnes PD, Robertson RR, Wong G, Mehta TS. Fast MR imaging of fetal central nervous system abnormalities. Radiology 2003;229:51-61.
39. Levine D. Obstetric MRI. J Magn Reson Imaging 2006;24:1-15.
40. Levine D, Barnewolt CE, Mehta TS, Trop I, Estroff J, Wong G Fetal thoracic abnormalities: MR imaging. Radiology 2003;228:379-88.
41. Baker PN, Johnson IR, Gowland PA, Hykin J, Adams V, Mansfield P, et al. Measurement of fetal liver, brain and placental volumes with echo-planar magnetic resonance imaging. Br J Obstet Gynaecol 1995;102:35-9.
42. Miller DA, CholletJA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 1997;177:210-4.
43. Ha TP, Li KC. Placenta accreta: MRI antenatal diagnosis and surgical correlation. J Magn Reson Imaging 1998;8: 748-50.
44. Thorp JM Jr, Councell RB, Sandridge DA, Wiest HH. Antepartum diagnosis of placenta previa percreta by magnetic resonance imaging. Obstet Gynecol 1992;80:506-8.
45. Maldjian C, Adam R, Pelosi M, Pelosi M 3rd, Rudelli RD, Maldjian J. MRI appearance of placenta percreta and placenta accreta. Magn Reson Imaging 1999;17:965-71.
46. Levine D, Hulka CA, Ludmir J, Li W, Edelman RR. Placenta accreta: evaluation with color Doppler US, power Doppler US, and MR imaging. Radiology 1997;205:773-6.
47. Palacios Jaraquemada JM, Bruno CH. Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings. Acta Obstet Gynecol Scand 2005;84:716-24.
48. Shellock FG, Crues JV. MR procedures: biologic effects, safety, and patient care. Radiology 2004;232: 635-52.
49. Saito K, Suzuki H, Suzuki K. Teratogenic effects of static magnetic field on mouse fetuses. Reprod Toxicol 2006;22:118-24.
50. Saunders R. Static magnetic fields: animal studies. Prog Biophys Mol Biol 2005;87:225-39.
51. Health Protection Agency, Radiation Protection Division. Protection of patients and volunteers undergoing MRI procedures: a document for consultation. Available at: http://www. hpaorg.uk/web/HPAwebFile/HPAweb- C/1204186243177. Retrieved May 29, 2008.
52. The International Commission on Non-Ionizing Radiation Protection. Medical magnetic resonance (MR) procedures: protection of patients. Health Phys 2004;87:197-216.
53. Eswaran H, Haddad NI, Shihabuddin BS, Preissl H, Siegel ER, Murphy P, et al. Non-invasive detection and identification of brain activity patterns in the developing fetus. Clin Neurophysiol 2007;118:1940-6.
54. McBride MC, Laroia N, Guillet R Electrographic seizures in neonates correlate with poor neurodevelopmental outcome. Neurology 2000;55:506-13.